The West Virginia University Flow Cytometry Core was established in 2001 as part of the Phase 1 Center for Biomedical Research Excellence (CoBRE) grant in Signal Transduction and Cancer submitted by the Mary Babb Randolph Cancer Center (MBRCC). The Flow Cytometry Core offers analytic flow cytometry and cell sorting to WVU and neighboring institutions, and supports CoBRE investigators as well as other NIH-funded projects. This application describes 1) the Core's past contribution to research at WVU, 2) selected specific scientific projects in cancer research that are NIH funded and dependent on the Flow Cytometry Core, 3) core personnel, and 4) the Core's operational plan. As a consistent goal within the CoBRE grants at all Phases (1-111) the Core will continue efforts to contribute to training and mentoring of investigators that utilize this resource. This will occur, in part, through participation in the Technology Seminar Series which is overseen by the Administrative Core. This seminar series provides the opportunity for MBRCC investigators, as well as other scientists who utilize the core, to be exposed to Flow Cytometry-based technologies that may augment their research. The Director of the Core will continue to attend classes and workshops for training in new technologies that will continue to support this Core as a dynamic resource that is responsive to changing research trends and investigator needs. The Facility will continue to play an integral role in current and future cancer-related projects including research projects designed to translate novel and innovative therapies to cancer patients in West Virginia. Finally, a strategy to ensure sustainability of the Flow Cytometry Core beyond Phase 111 of the CoBRE program is described in the following section as an essential consideration to the long-term growth of the MBRCC and our capacity to continue to provide optimal access to appropriate technology.

Public Health Relevance

The Flow Cytometry Core is an integral component of the CoBRE in Signal Transduction and Cancer. The CoBRE supports biomedical research in cancer at WVU, which has the goal of improving patient health by understanding mechanisms of cancer cell signaling, and translating that information to developing new therapies for cancer.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-B (01))
Program Officer
Zlotnik, Hinda
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
West Virginia University
United States
Zip Code
Boehm, Dylan T; Hall, Jesse M; Wong, Ting Y et al. (2018) Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice. Infect Immun 86:
Nichols, Cody E; Shepherd, Danielle L; Hathaway, Quincy A et al. (2018) Reactive oxygen species damage drives cardiac and mitochondrial dysfunction following acute nano-titanium dioxide inhalation exposure. Nanotoxicology 12:32-48
McNitt, Dudley H; Choi, Soo Jeon; Keene, Douglas R et al. (2018) Surface-exposed loops and an acidic patch in the Scl1 protein of group A Streptococcus enable Scl1 binding to wound-associated fibronectin. J Biol Chem 293:7796-7810
Shumar, Stephanie A; Kerr, Evan W; Geldenhuys, Werner J et al. (2018) Nudt19 is a renal CoA diphosphohydrolase with biochemical and regulatory properties that are distinct from the hepatic Nudt7 isoform. J Biol Chem 293:4134-4148
Famodu, Oluremi A; Barr, Makenzie L; Colby, Sarah E et al. (2018) Neck Circumference Positively Relates to Cardiovascular Risk Factors in College Students. Int J Environ Res Public Health 15:
MacFawn, Ian; Wilson, Hannah; Selth, Luke A et al. (2018) Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers. Mol Immunol 105:137-149
Li, Bingyun; Webster, Thomas J (2018) Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections. J Orthop Res 36:22-32
Rodgers, H M; Huffman, V J; Voronina, V A et al. (2018) The role of the Rx homeobox gene in retinal progenitor proliferation and cell fate specification. Mech Dev 151:18-29
Nair, Rajesh R; Geldenhuys, Werner J; Piktel, Debbie et al. (2018) Novel compounds that target lipoprotein lipase and mediate growth arrest in acute lymphoblastic leukemia. Bioorg Med Chem Lett 28:1937-1942
Shah, Neal; Mohammad, Afroz S; Saralkar, Pushkar et al. (2018) Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases. Pharmacol Res 132:47-68

Showing the most recent 10 out of 158 publications